Citalopram doesn't benefit autistic children, study finds

06/2/2009 | Wall Street Journal, The

A large, government-funded trial found no evidence that citalopram, an antidepressant, minimizes repetitive behaviors in children with autism-spectrum disorders. The study showed a "placebolike response" of about 30% regardless of whether patients received citalopram or placebo for 12 weeks, researchers reported.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR